With the introduction of the Cannabis Act in 2018, Canada was the second jurisdiction (after Uruguay) to legalize cannabis at a national level for adult recreational use. Given this substance was illegal for over 90 years, and ending this prohibition was unprecedented for Canadian society, Parliament mandated a review of the Act within three years...Read More
In recent years, the field of mental health treatment has witnessed a revolutionary approach with the emergence of psychedelic-assisted therapies. Because of its status as a controlled substance, ketamine-assisted therapy is at the forefront of this movement, with MDMA and psilocybin close on its tail. Once again, Alberta is proving to be a leader of...Read More
New Survey Shows 83% of Canadians Approve of Free Prescription Birth Control Across Canada 7 in 10 Feel it is an Urgent Issue NEWS RELEASE – Calgary, Alberta, Canada – August 15, 2023 A new survey conducted by Abacus Data, an Ottawa polling firm, shows exceptionally high approval amongst Canadians for federal universal coverage of...Read More
TORONTO, Aug. 2, 2023 /PRNewswire/ — As Canada approaches the 5th anniversary of cannabis legalization, Labstat Inc., a leader in tobacco/nicotine, cannabis, hemp and NHP laboratory testing and research & development, underscores the need for more robust regulations and increased research funding to continue leading the way for the international community in this area. “We need...Read More
New Federal Petition Calling for Free Birth Control in Canada Starts with Strong Support Calgary, Alberta, Canada – August 1, 2023, 10:00 a.m. MT House of Commons Petition E-4516, advocating for Federal Universal Coverage of Contraception, went live on July 27, 2023 and has already garnered over 600 signatures, the minimum amount required to be...Read More
Having participated in several meetings with the Competition Bureau between 2022 and 2023, we are pleased to see that their recent submission to Health Canada reflects our views and that of the industry. We believe strongly in the opportunities this industry has to offer and will continue to advocate on improving the Act (and the...Read More
Part 2 in the Mythbusters Series Welcome to part 2 of our Mythbusters series, where we’re bringing the data to light. Today’s topic is opioids. This is a heavy area of focus, especially in light of the increases in opioid mortality. We also do not expect our data finding to be the all-encompassing solution to...Read More
Part 1 in the Mythbusters Series As advocates for safety in the cannabis industry, we are always on the lookout for new statistics. We found many striking realities when it comes to cannabis and the effect it has on communities. Over the next 3 posts, we’re going to lay out 3 main realities when it...Read More
Original post date: January 2023 It has been over four years since the Cannabis Act was implemented, and in that time, consumers, patients, and governments have had the opportunity to discern which policies and regulations are working, and which ones need to be revised. Diplomat Consulting advises various stakeholders on ways to advocate for legislative...Read More
It stunned many, but it was a true story. Alberta, arguably one of the more politically conservative provinces in Canada, has developed their own framework for access to psychedelic therapy treatments. And the day of that program launch, is today. But what is the program? How does it work? Are psychedelics legal in Alberta? Reach...Read More
